Brazilian Diabetes Prevention Program: Pilot Study
PROVEN-Dia
1 other identifier
interventional
220
1 country
5
Brief Summary
To structure a Brazilian Diabetes Prevention Program based on guidance for changing lifestyle promoted by the American Diabetes Prevention Program, using materials already developed by the Brazilian Ministry of Health and contextualizing it to the Brazilian Public Health System (SUS) and evaluating its effectiveness in a multicentric randomized clinical trial with 220 pre-diabetic patients and a follow up of 3 months. Outcomes are diet quality and time of physical activity. Health care professionals' perceptions regarding its incorporation into clinical practice will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 23, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedStudy Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedJanuary 30, 2024
January 1, 2024
5 months
December 23, 2022
January 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Quality of diet
to compare mean score of Brazilian Cardioprotective Nutritional Program dietary index (BALANCE DI) between groups. the index has a score from 0 to 40, with a high score indicating adherence to a healthy diet (BALANCE).
3 months
Minutes of Moderate Physical activity
to compare mean time in minutes of practice of moderate/vigorous physical activity over a week between groups
3 months
Secondary Outcomes (7)
Implementation Barriers and Facilitators
3 months
Moderate or vigorous physical activity (according to IPAQ-short)
3 months
Cardioprotective diet adherence
3 months
Global DNA Methylation
Baseline and 3 months
weight
3 months
- +2 more secondary outcomes
Study Arms (2)
Brazilian Diabetes Prevention Program Group
EXPERIMENTALThe program will be based on the American Diabetes Prevention Program (DPP), whose published results are used as a reference for prediabetic care patients in the Brazilian Diabetes Guideline. In order to reach the weight loss goal estimated at 0.5 to 1 Kg per week and 150 minutes of moderate physical activity per week, the program will offer individual and group visits, qualitative guidelines for improving diet, lifestyle and self-care.
Diet Group
ACTIVE COMPARATORDiet prescription for weight loss
Interventions
A Program structured in 7 visits (in group and individual) to guide the improvement of diet quality, self-care, and practice of physical activity
Eligibility Criteria
You may qualify if:
- Body mass index greater than or equal to 24kg/m2
- Have one of the following criteria: (CDC criteria for participating in the DPP)
- Diagnosis of prediabetes or
- Fasting blood glucose between 100-125mg/dl or blood glucose 2h after oral glucose tolerance test between 140 and 199mg/dl or HbA1c between 5.7 and 6.4% (maximum test date: last 3 months) or
- Previously diagnosed with gestational diabetes or
- High risk on the CDC prediabetes risk test
- With Internet access
- With personal cell phone access
- No prior nutritional monitoring (6 months)
- Live at least 60 minutes from the survey call center
You may not qualify if:
- Diagnosis of Diabetes Mellitus
- In secondary prevention for cardiovascular disease
- HIV patient with detectable viral load (amount of virus greater than 40 copies per ml of blood)
- Presence of illnesses that could seriously reduce your life expectancy or your ability to participate in the study
- Refuse to participate in the study (signing the Free and Informed Consent Form)
- Participation in another Randomized Clinical Trial whose objective interferes with the primary outcome of this research, such as diet quality and physical activity level
- Pregnant and lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Hospital Universitário Professor Edgard Santos - HUPES
Salvador, Estado de Bahia, Brazil
Hospital de Clínicas de Goiania
Goiânia, Goiás, Brazil
Universidade Federal de Viçosa
Viçosa, Minas Gerais, Brazil
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Universidade Federal do Tocantins
Palmas, Tocantins, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 23, 2022
First Posted
January 19, 2023
Study Start
March 15, 2023
Primary Completion
August 4, 2023
Study Completion
October 31, 2023
Last Updated
January 30, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share